FNFDCM
LH icon

Folger Nolan Fleming Douglas Capital Management’s Labcorp LH Stock Holding History

Folger Nolan Fleming Douglas Capital Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$576K Buy
2,057
+5
+0.2% +$1.31K 0.05% 114
2026
Q1 		$547K Buy
2,052
+365
+22% +$98.8K 0.05% 115
2025
Q4 		$423K Sell
1,687
-70
-4% -$18.6K 0.04% 121
2025
Q3 		$504K Buy
1,757
+5
+0.3% +$1.34K 0.05% 110
2025
Q2 		$460K Sell
1,752
-241
-12% -$58.7K 0.05% 118
2025
Q1 		$464K Sell
1,993
-97
-5% -$23.5K 0.05% 117
2024
Q4 		$479K Sell
2,090
-2,596
-55% -$596K 0.05% 115
2024
Q3 		$1.05M Sell
4,686
-1,535
-25% -$337K 0.1% 82
2024
Q2 		$1.27M Sell
6,221
-245
-4% -$49.8K 0.13% 76
2024
Q1 		$1.41M Sell
6,466
-90
-1% -$19.8K 0.14% 73
2023
Q4 		$1.49M Hold
6,556
– – 0.16% 71
2023
Q3 		$1.32M Sell
6,556
-1,105
-14% -$233K 0.15% 72
2023
Q2 		$1.59M Sell
7,661
-326
-4% -$63.2K 0.17% 67
2023
Q1 		$1.57M Sell
7,987
-216
-3% -$44.4K 0.18% 67
2022
Q4 		$1.73M Sell
8,203
-134
-2% -$26.2K 0.21% 65
2022
Q3 		$1.47M Buy
8,337
+140
+2% +$28.7K 0.2% 64
2022
Q2 		$1.65M Buy
8,197
+122
+2% +$26K 0.22% 62
2022
Q1 		$1.83M Buy
8,075
+204
+3% +$48K 0.2% 63
2021
Q4 		$2.13M Sell
7,871
-431
-5% -$107K 0.23% 63
2021
Q3 		$2.01M Buy
8,302
+210
+3% +$52.9K 0.24% 61
2021
Q2 		$1.92M Buy
8,092
+292
+4% +$66.5K 0.22% 64
2021
Q1 		$1.71M Buy
7,800
+279
+4% +$56K 0.21% 65
2020
Q4 		$1.31M Sell
7,521
-312
-4% -$53.9K 0.17% 72
2020
Q3 		$1.27M Buy
7,833
+305
+4% +$48.3K 0.19% 67
2020
Q2 		$1.07M Buy
7,528
+233
+3% +$32.2K 0.17% 71
2020
Q1 		$792K Buy
7,295
+82
+1% +$11.8K 0.16% 81
2019
Q4 		$1.05M Buy
7,213
+58
+0.8% +$8.37K 0.15% 78
2019
Q3 		$1.03M Buy
7,155
+495
+7% +$72.2K 0.16% 74
2019
Q2 		$989K Buy
6,660
+390
+6% +$54.4K 0.15% 77
2019
Q1 		$824K Buy
6,270
+343
+6% +$42.3K 0.12% 83
2018
Q4 		$643K Buy
5,927
+623
+12% +$83.5K 0.11% 90
2018
Q3 		$791K Buy
5,304
+1,815
+52% +$276K 0.11% 87
2018
Q2 		$538K Buy
3,489
+548
+19% +$82.7K 0.08% 104
2018
Q1 		$409K Hold
2,941
– – 0.06% 114
2017
Q4 		$403K Hold
2,941
– – 0.06% 120
2017
Q3 		$381K Hold
2,941
– – 0.06% 120
2017
Q2 		$389K Hold
2,941
– – 0.06% 120
2017
Q1 		$363K Buy
2,941
+116
+4% +$13.7K 0.05% 125
2016
Q4 		$339K Hold
2,825
– – 0.06% 126
2016
Q3 		$339K Hold
2,825
– – 0.06% 126
2016
Q2 		$316K Buy
2,825
+23
+0.8% +$2.48K 0.05% 131
2016
Q1 		$282K Hold
2,802
– – 0.05% 133
2015
Q4 		$298K Hold
2,802
– – 0.05% 130
2015
Q3 		$261K Buy
2,802
+780
+39% +$80.7K 0.05% 139
2015
Q2 		$211K Sell
2,022
-134
-6% -$13.9K 0.04% 149
2015
Q1 		$234K Buy
+2,156
New +$222K 0.04% 146
2014
Q1 		– Sell
-3,149
Closed -$247K – 167
2013
Q4 		$247K Hold
3,149
– – 0.04% 139
2013
Q3 		$268K Buy
3,149
+350
+13% +$29.5K 0.05% 136
2013
Q2 		$241K Buy
+2,799
New +$232K 0.05% 129

Other funds holding LH

RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
DIA
Davidson Investment Advisors Great Falls, Montana $2.45B AUM 21.8% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
HPCM
Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return
MCM
McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return
ET
Equitable Trust Nashville, Tennessee $2.4B AUM 30.76% 1-Year Est. Return

Folger Nolan Fleming Douglas Capital Management's LH Position: Q2 2026 in Review

Folger Nolan Fleming Douglas Capital Management increased its Labcorp (LH) stake by 0.24% in Q2 2026, buying an estimated $1.31K and bringing the position to 2,057 shares worth $576K. The position accounts for 0.05% of the portfolio, ranked #114.

Folger Nolan Fleming Douglas Capital Management first reported a position in LH in Q2 2013 and has held it in 49 quarters since. The position peaked at $2.13M in Q4 2021. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Folger Nolan Fleming Douglas Capital Management held 2,057 shares of Labcorp worth $576K as of Q2 2026.
  • Folger Nolan Fleming Douglas Capital Management bought 5 Labcorp shares in Q2 2026, an estimated $1.31K.
  • Labcorp made up 0.05% of Folger Nolan Fleming Douglas Capital Management's portfolio in Q2 2026, its #114 holding.
  • Folger Nolan Fleming Douglas Capital Management first reported a position in Labcorp in Q2 2013 and has held it in 49 quarters since.
  • Folger Nolan Fleming Douglas Capital Management's Labcorp position peaked at $2.13M in Q4 2021.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.